ER–/PR+ subset of invasive breast carcinoma (IBC): a distinct phenotype with good prognosis

The expression of the estrogen (ER) and progesterone (PR) receptors in IBC patients represents a well-know prognostic and predictive factor. The existence of ER–/PR+ as a distinct phenotype, however, is controversial as well as is its prognostic significance. The aim of the study was to assess the i...

Full description

Bibliographic Details
Published in:	Polish Journal of Pathology
Main Authors:	Simona Stolnicu, Orsolya Bauer, Adrian Naznean, Cristian Podoleanu, Rareş Georgescu
Format:	Article
Language:	English
Published:	Termedia Publishing House 2018-11-01
Subjects:	breast pathology breast cancer immunohistochemistry hormone receptors management
Online Access:	https://www.termedia.pl/ER-PR-subset-of-invasive-breast-carcinoma-IBC-a-distinct-phenotype-with-good-prognosis,55,34121,1,1.html

Similar Items

Relation of Nuclear Morphometry with Clinicopathologic Prognostic Parameters and Immunohistochemical ER, PR and Cerb-B2 Expressions in Breast Carcinoma
by: Murat ÇELİK, et al.
Published: (2021-08-01)

Differences in GATA3 expression among histological/molecular subtypes and grades in infiltrating breast carcinoma (IBC) are important in the diagnosis of metastatic breast carcinoma
by: Simona Stolnicu, et al.
Published: (2020-05-01)

Predictors of molecular subtypes in women with breast cancer in Rwanda
by: F. Ntirenganya, et al.
Published: (2023-01-01)

Correlation of Ki67 expression with estrogen receptor (ER) and progesterone receptor (PR) status in breast cancer
by: Dedy Hermansyah, et al.
Published: (2025-08-01)

Immunohistochemical analysis of angiogenesis in invasive ductal breast carcinoma with correlations to clinic pathological factor
by: Ivković-Kapicl Tatjana, et al.
Published: (2006-01-01)

Pathologically confirmed women's breast cancer: A descriptive study of Tunisian and Algerian series
by: Farah Sassi, et al.
Published: (2023-09-01)

Case Report: Advanced breast invasive ductal carcinoma with erysipeloid cutaneous metastasis misdiagnosed as erysipelas
by: Weiju Gu, et al.
Published: (2025-07-01)

Clinicopathological and immunohistochemical basis for sonographic characteristics of triple-negative invasive breast cancer
by: 李佳伟, et al.
Published: (2019-02-01)

Racial and survival disparities in inflammatory breast cancer (IBC) and non-IBC: a population-based study focused on Native Hawaiians and other Pacific Islanders
by: Gene T. Yoshikawa, et al.
Published: (2024-05-01)

The Role of Pedobarography and Therapeutic Padding in the Management of Hyperkeratosis due to Mechanical Stress
by: Chiriac Anca, et al.
Published: (2019-03-01)

Expression of C-terminal tensin-like in breast carcinoma and its correlation with known prognostic factors
by: Usma Arshad, et al.
Published: (2025-05-01)

Challenges and improvements in HER2 scoring and histologic evaluation: insights from a national proficiency testing scheme for breast cancer diagnosis in China
by: Xuemin Xue, et al.
Published: (2024-09-01)

Pigmented cutaneous metastasis of breast carcinoma: florid case with zosteriform distribution
by: Francilene M. Peçanha, et al.
Published: (2024-04-01)

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
by: Jie Zheng, et al.
Published: (2023-06-01)

Comparative histopathology and immunohistochemistry of human and canine mammary tumors
by: Munsef A. Al-Mansour, et al.
Published: (2018-07-01)

Immunohistochemical Survey of Invasive Ductal Carcinoma of the Breast, using ER, PR, HER2 and KI-67 biomarkers, in Uyo, Nigeria
by: Eziagu UB, et al.
Published: (2022-09-01)

Association of Expression Patterns of ER, PR, HER-2/neu and Ki67 with Nottingham Tumor Grade in Breast Cancer Biopsies
by: Shireen Hamid, et al.
Published: (2026-06-01)

Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience
by: Francesco Pepe, et al.
Published: (2025-09-01)

AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
by: Nelson Rangel, et al.
Published: (2020-04-01)

Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls
by: Kai CC Johnson, et al.
Published: (2023-12-01)

Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer
by: Cvetka Grašič Kuhar, et al.
Published: (2023-06-01)

Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China: results from a pilot work of National Single Disease Quality Control Program for breast cancer
by: Xuemin Xue, et al.
Published: (2024-01-01)

Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma
by: Mehenaz Hanbazazh, et al.
Published: (2023-12-01)

Building pathology capacity in sub-Saharan Africa to improve breast cancer diagnosis and treatment: training laboratory technicians in high-quality manual immunohistochemistry
by: Linda Setiawan, et al.
Published: (2024-01-01)

<em>FGFR</em>1 protein level is associated with ER expression and prognosis in ER-positive breast cancer
by: 王宇航, et al.
Published: (2019-06-01)

Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges
by: Marie Brevet, et al.
Published: (2024-12-01)

FOXA1 expression in Iraqi women with ER+ breast cancer
by: Iman Al-Bedairy, et al.
Published: (2020-06-01)

A slowly growing blue nodule on the scalp
by: Justin Lee, BS, et al.
Published: (2020-12-01)

Diagnostic Algorithm for Superficial Venous Malformations in Newborns
by: Chiriac Anca E., et al.
Published: (2018-12-01)

Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
by: Piotr Ziółkowski, et al.
Published: (2022-09-01)

A rare and distinct bilateral ovarian tumor: Carcinosarcoma
by: Faten Limaiem, et al.
Published: (2021-12-01)

Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology
by: Sven Kurbel, et al.
Published: (2017-03-01)

Unexpected hyperechoic lesions of the breast and their correlations with pathology: a pictorial essay
by: Seo Young Park, et al.
Published: (2022-07-01)

Survey of low ER-positive expression and its correlation with other clinical and pathological factors in breast cancer
by: Atena Azami, et al.
Published: (2020-01-01)

Primary breast neuroendocrine carcinoma: a case report and literature review
by: CHEN Jiaying, et al.
Published: (2024-03-01)

Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
by: Elham Sajjadi, et al.
Published: (2023-04-01)

Predictive Value of Histologic Characteristics on Hormone Receptor and HER-2 Status of Patients with Invasive Breast Carcinoma, No Special Type, in an Academic Medical Center
by: Kevin Elomina, et al.
Published: (2019-03-01)

Secretory Carcinoma of the Breast
by: Fatma Aktepe, et al.
Published: (2016-10-01)

Immunohistochemical expression and correlation of mammaglobin with the grading system of breast carcinoma
by: Rehman Fakeha, et al.
Published: (2010-10-01)

Mammary Paget’s disease without underlying malignancy of the breast
by: Nuri Jang, et al.
Published: (2018-06-01)